Clozapine-Induced Lupus Erythematosus [6]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 2, 2004, Pages 236-238

  Wolf, Joachim ^a,b   Sartorius, Alexander ^b   Alm, Barbara ^b   Henn, Fritz A ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTINUCLEAR ANTIBODY; CLOZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTHRALGIA; CASE REPORT; DRUG INDUCED DISEASE; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; LETTER; LUPUS ERYTHEMATOSUS; MYALGIA; PARANOID SCHIZOPHRENIA; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SCHIZOPHRENIA, PARANOID;

EID: 1642307070     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000117430.83724.f9     Document Type: Letter

References (15)

1. Rubin RL. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol. 1999;11:357-363.
2. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am. 1994;20:61-86.
3. Fitton A, Heel RC. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs. 1990;40(5):722-747.
4. Kane JM. Management strategies for the treatment of schizophrenia. J Clin Psychiatry. 1999;(60 suppl 12):13-17.
5. Lieberman JA, Safferman AZ, Pollack S, et al. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry. 1994;151(12):1744-1752.
6. Hippius H. A historical perspective of clozapine. J Clin Psychiatry. 1999;(60 suppl 12):22-23.
7. Wickert WA, Campbell NR, Martin L. Acute severe adverse clozapine reaction resembling systemic lupus erythematosus. Postgrad Med J. 1994;70:940-941.
8. Catalano G, Catalano MC, Frankel Wetter RL. Clozapine induced polyserositis. Clin Neuropharmacol. 1997;20:352-356.
9. Hagg S, Spigset O, Bate A, et al. Myocarditis related to clozapine treatment. J Clin Psychopharmacol. 2001;21:382-388.
10. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354:1841-1845.
11. Reznik J, Volchek L, Mester R, et al. Myotoxicity and neurotoxicity during clozapine treatment. Clin Neuropharmacol. 2000;23:276-280.
12. Scelsa SN, Simpson DM, McQuistion HL, et al. Clozapine-induced myotoxicity in patients with chronic psychotic disorders. Neurology. 1996;47:1518-1523.
13. Alphs LD, Meltzer HY, Bastani B, et al. Side effects of clozapine and their management. Pharmacopsychiatry. 1991;24(2):46.
14. Hess EV, Mongey AB. Drug related lupus. Bull Rheum Dis. 1991;40:1-8.
15. Pollmächer T, Haack M, Schuld A, et al. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res. 2000;34:369-382.